Disease severity associated with cystic fibrosis mutations deltaF508 and S549R(T-->G)

K P Dawson1, P M Frossard, B Al-Awar

  • 1Department of Paediatrics, Faculty of Medicine and Health Science, UAE University, Al-Ain, United Arab Emirates.

Insights

The cystic fibrosis (CF) mutations S549R(T-->G) and deltaF508 present similarly severe clinical symptoms in children. These CF mutations result in comparable illness severity, making them indistinguishable based on clinical presentation.

Area of Science:

  • Medical Genetics
  • Pediatrics
  • Pulmonology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
  • Specific CFTR gene mutations influence disease severity.
  • Understanding mutation-specific clinical presentations is crucial for patient management.

Purpose of the Study:

  • To compare the clinical severity of two distinct cystic fibrosis mutations: S549R(T-->G) and deltaF508.
  • To evaluate clinical and biochemical variables in children with these CF mutations in the United Arab Emirates (UAE).

Main Methods:

  • Comparative analysis of clinical and biochemical data.
  • Age- and sex-matched cohorts of pediatric CF patients in the UAE.
  • Assessment of Shwachman scores and sweat chloride levels.

Main Results:

  • Both S549R(T-->G) and deltaF508 homozygous mutations exhibited severe clinical phenotypes.
  • Patients displayed comparable very low Shwachman scores, indicating significant pancreatic insufficiency.
  • High sweat chloride levels were observed in both groups, consistent with CF diagnosis.

Conclusions:

  • The CF mutations deltaF508 and S549R(T-->G) lead to indistinguishable severe clinical presentations.
  • Homozygous patients for these mutations show comparable disease severity on clinical grounds.
  • This finding aids in understanding genotype-phenotype correlations in cystic fibrosis.

Related Concept Videos

Mutations01:39

Mutations

Overview
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...